HLA-DR Antikörper (FITC)
-
- Target Alle HLA-DR Produkte
- HLA-DR
-
Reaktivität
- Human, Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DR Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS)
- Aufreinigung
- Affinity chromatography on Protein G
- Immunogen
- EHR-B Ramos cells. Spleen cells from immunised AO rats were fused with cells of the rat Y3 Ag1.2.3 myeloma cell line.
- Klon
- YE2-36-HLK
- Isotyp
- IgG2a
-
-
- Applikationshinweise
-
Flow Cytometry: Neat - 1/10, Use 10 μL of the suggested working dilution to label 10^6 cells in 100 μL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.1 mg/mL
- Buffer
- Containing 0.09 % Sodium Azide and 1 % Bovine Serum Albumin
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing. Should this product contain a precipitate we recommend microcentrifugation before use.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- HLA-DR
- Andere Bezeichnung
- HLA Class II DR (HLA-DR Produkte)
- Hintergrund
- HLA DR is expressed by B lymphocytes, activated T cells and by monocytes.Synonyms: HLA class II histocompatibility antigen DR, HLA-DR, MHC class II antigen DR
- Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-